Summary
The NEW EU Pharma legislation has almost landed.
In March 2026, the text of the reform of the EU pharmaceutical regulation was published. Though small changes may still occur, this is very close to the final text that establishes the regulatory framework likely to govern Medicinal products in the EU for the next 20-30 years.
Associate Professor in EU Pharmaceutical Law Jakob Wested gives you a 45-minute overview of what's new and opens the discussion on the practical and strategic implications ahead.
Key words
Pharma Legislation
Save information for later
Course leader & lecturers
- Jakob WestedLecturerAssociate professor
Københavns Universitet
Is this webinar for you?
If you work in pharma or in the public sector as a regulatory professional, lawyer, clinical trial professional, monitor, or similar role, you will benefit from joining and leave with a solid grasp of what has changed and where to focus your attention.
What you will learn
- An overview of the NEW pharma legislation
- A head starts with the content of the NEW pharma legislation
- Learn what’s NEW
- Insight into the practical and strategic implications ahead
What your company will get
- An employe who has an overview of the NEW pharma legislation
- An employe who has got a head starts with the content of the NEW pharma legislation
- An employe who has learned what’s NEW
- An employe who has insight into the practical and strategic implications ahead
Calendar
More information to follow
Course leader
Lecturer
Københavns Universitet
You may also be interested in these courses
3 Nov 2026
•
Want to know more or need help?
Contact Client Manager Louise V. Petersen at +45 40 44 99 43
Send me a message